Recent LGVN News
- Longeveron® Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B™ in Hypoplastic Left Heart Syndrome (HLHS) • GlobeNewswire Inc. • 09/03/2024 01:00:00 PM
- Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 08/26/2024 08:05:00 PM
- Cisco Beats Estimates and Announces Restructuring, Canoo Rises 6%, Lulus Losses Widen, Latest in Earnings • IH Market News • 08/15/2024 10:08:19 AM
- Longeveron® Announces Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/14/2024 08:05:00 PM
- U.S. Futures Steady After Tuesday’s Strong Recovery; CPI in Focus • IH Market News • 08/14/2024 09:58:49 AM
- Longeveron® to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024 • GlobeNewswire Inc. • 08/05/2024 08:05:00 PM
- Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (AAIC) • GlobeNewswire Inc. • 07/28/2024 08:51:00 PM
- Longeveron Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 07/19/2024 08:05:00 PM
- Longeveron Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 07/18/2024 12:45:00 PM
- Longeveron® Announces U.S. FDA Grants Fast Track Designation for Lomecel-B™ for the Treatment of Mild Alzheimer’s Disease • GlobeNewswire Inc. • 07/17/2024 12:00:00 PM
- Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer’s Disease • GlobeNewswire Inc. • 07/10/2024 11:30:00 AM
- Neha Motwani Elected to Longeveron® Board of Directors • GlobeNewswire Inc. • 07/09/2024 01:00:00 PM
- Gene Therapy Pioneer Roger Hajjar, MD, Elected to Longeveron® Board of Directors • GlobeNewswire Inc. • 07/08/2024 01:00:00 PM
- Life Science Virtual Investor Forum Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 06/21/2024 12:35:00 PM
- Longeveron Raises $4.4 Million in Gross Proceeds from Warrant Exercise Transaction • GlobeNewswire Inc. • 06/18/2024 08:48:38 PM
- Longeveron® to Present at the Virtual Life Sciences Investor Forum on June 20, 2024 • GlobeNewswire Inc. • 06/17/2024 01:00:00 PM
- Longeveron Announces Exercise of Warrants for $4.4 Million Gross Proceeds • GlobeNewswire Inc. • 06/17/2024 12:38:31 PM
- Longeveron® Announces Completion of Successful Investigator Meeting for On-going Phase 2b Clinical Trial Evaluating Lomecel-B™ as a Potential Treatment for HLHS, a Rare Pediatric Cardiac Disease • GlobeNewswire Inc. • 06/11/2024 01:00:00 PM
- Longeveron® Announces Contract Development and Manufacturing Business and First Contract • GlobeNewswire Inc. • 06/03/2024 01:00:00 PM
- Longeveron® to Attend BIO International Convention 2024 • GlobeNewswire Inc. • 05/28/2024 12:05:00 PM
- Longeveron Announces First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/14/2024 08:05:00 PM
- Longeveron Announces Board of Directors Planned Transitions • GlobeNewswire Inc. • 05/10/2024 08:05:00 PM
- Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 • GlobeNewswire Inc. • 05/02/2024 12:03:00 PM
- Longeveron to Present at the Planet MicroCap Showcase • GlobeNewswire Inc. • 04/25/2024 08:05:00 PM
- Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering • GlobeNewswire Inc. • 04/18/2024 08:05:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM